Early detection of lung cancer in serum by a panel of MicroRNA biomarkers

Clinical Lung Cancer

Volumn 16, Issue 4, 2015, Pages 313-319.e1

  Wang, Ping ^a,d   Yang, Dawei ^b   Zhang, Honglian ^a   Wei, Xuyu ^c   Ma, Tianle ^c   Cheng, Zule ^a,d   Hong, Qunying ^b   Hu, Jie ^b   Zhuo, Hanjing ^b   Song, Yuanlin ^b   Jia, Chunping ^a   Jing, Fengxiang ^a   Jin, Qinghui ^a   Bai, Chunxue ^b   Mao, Hongju ^a   Zhao, Jianlong ^a  

^a SHANGHAI INSTITUTE OF MICROSYSTEM AND INFORMATION TECHNOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Biomarker; Early detection; Lung cancer; MicroRNA; Serum

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MICRORNA; MICRORNA 125A 5P; MICRORNA 126; MICRORNA 25; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOINFORMATICS; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EARLY CANCER; FEMALE; HUMAN; LUNG CANCER; MALE; QUANTITATIVE ASSAY; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SMOKING; VALIDATION STUDY; AGED; BLOOD; CANCER STAGING; CASE CONTROL STUDY; EARLY CANCER DIAGNOSIS; GENETICS; LUNG NEOPLASMS; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION;

AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84930762021     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2014.12.006     Document Type: Article

References (35)

1. M. Saito, A.J. Schetter, and S. Mollerup The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts Clin Cancer Res 17 2011 1875 1882
2. P.Y. Lin, and P.C. Yang Circulating miRNA signature for early diagnosis of lung cancer EMBO Mol Med 3 2011 436 437
3. P.T. Hennessey, T. Sanford, and A. Choudhary Serum microRNA biomarkers for detection of non-small cell lung cancer PLoS One 7 2012 e32307
4. C. Camps, L. Jantus, and M. Usó Update on biomarkers for the detection of lung cancer Lung Cancer Targets Ther 3 2012 21 29
5. F. Jiang, N.W. Todd, and R. Li A panel of sputum-based genomic marker for early detection of lung cancer Cancer Prev Res (Phila) 3 2010 1571 1578
6. J. Shen, N.W. Todd, and H. Zhang Plasma microRNAs as potential biomarkers for non-small-cell lung cancer Lab Invest 91 2011 579 587
7. D. Zheng, S. Haddadin, and Y. Wang Plasma microRNAs as novel biomarkers for early detection of lung cancer Int J Clin Exp Pathol 4 2011 575 587
8. G. Tarro, A. Perna, and C. Esposito Early diagnosis of lung cancer by detection of tumor liberated protein J Cell Physiol 203 2005 1 5
9. G. Heller, M. Weinzierl, and C. Noll Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers Clin Cancer Res 18 2012 1619 1629
10. M.T. Landi, Y. Zhao, and M. Rotunno MicroRNA expression differentiates histology and predicts survival of lung cancer Clin Cancer Res 16 2010 430 441
11. M. Redova, J. Sana, and O. Slaby Circulating miRNAs as new blood-based biomarkers for solid cancers Future Oncol 9 2013 387 402
12. X. Chen, Y. Ba, and L. Ma Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res 18 2008 997 1006
13. T.V. Colby, Wistuba II, and A. Gazdar Precursors to pulmonary neoplasia Adv Anat Pathol 5 1998 205 215
14. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
15. E.M. Kroh, R.K. Parkin, and P.S. Mitchell Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) Methods 50 2010 298 301
16. X. Chen, Z. Hu, and W. Wang Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis Int J Cancer 130 2012 1620 1628
17. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative CT method Nat Protoc 3 2008 1101 1108
18. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 2002 2007
19. H.D. VanGuilder, K.E. Vrana, and W.M. Freeman Twenty-five years of quantitative PCR for gene expression analysis Biotechniques 44 2008 619 626
20. A. Keller, P. Leidinger, and R. Gislefoss Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis RNA Biol 8 2011 506 516
21. Q. Lin, W. Mao, and Y. Shu A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR J Cancer Res Clin Oncol 138 2012 85 93
22. Z.X. Wang, H.B. Bian, and J.R. Wang Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer J Surg Oncol 104 2011 847 851
23. F. Gao, J. Chang, and H. Wang Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients Oncol Rep 31 2014 351 357
24. L. Xing, N.W. Todd, and L. Yu Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers Mod Pathol 23 2010 1157 1164
25. J. Shen, and F. Jiang Applications of microRNAs in the diagnosis and prognosis of lung cancer Expert Opin Med Diagn 6 2012 197 207
26. X. Guo, Y. Wu, and R. Hartley MicroRNA-125a represses cell growth by targeting HuR in breast cancer RNA Biol 6 2009 575 583
27. L. Jiang, Q. Huang, and S. Zhang Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells BMC Cancer 10 2010 318 330
28. E.J. Nam, H. Yoon, and S.W. Kim MicroRNA expression profiles in serous ovarian carcinoma Clin Cancer Res 14 2008 2690 2695
29. P.F. Vazquez, M.J. Carlini, and M.C. Daroqui TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer Clin Exp Metastasis 30 2013 993 1007
30. R. Datta, S.K. Halder, and B. Zhang Role of TGF-beta signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells J Cancer Res Clin 139 2013 563 572
31. S. Qian, J.Y. Ding, and R. Xie MicroRNA expression profile of bronchioalveolar stem cells from mouse lung Biochem Biophys Res Commun 377 2008 668 673
32. L. Din, G. Getz, and D.A. Wheeler Somatic mutations affect key pathways in lung adenocarcinoma Nature 455 2008 1069 1075
33. E.K. Kim, and E.J. Choi Pathological roles of MAPK signaling pathways in human diseases Biochim Biophys Acta 1802 2010 396 405
34. M. Crawford, E. Brawner, and K. Batte MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines Biochem Biophys Res Commun 373 2008 607 612
35. H. Davies, C. Hunter, and R. Smith Somatic mutations of the protein kinase gene family in human lung cancer Cancer Res 65 2005 591 595